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Abstract
The generation of a tissue-specific intestinal hydrogel using small intestinal extracellular
matrix (ECM) has the potential to support and promote the growth of intestinal organoids. In
this study, we aimed to develop hydrogels derived exclusively from intestinal ECM or
composites comprised of intestinal ECM combined with alginate, which may allow greater
tuning of the hydrogel properties. A novel mouse intestinal decellularization protocol was
developed and the ECM was characterized. Our analysis demonstrates that cellular and
nuclear content was removed effectively, while preserving key ECM components. When
decellularized ECM was used to generate hydrogels, the resulting ECM displayed bioactivity
as demonstrated by metabolic and pro-proliferative effects on NIH 3T3 murine fibroblasts.
More importantly, our novel ECM hydrogel also supported intestinal organoid growth. These
studies demonstrate that tissue-specific ECM-derived hydrogels can indeed support and
promote the growth of intestinal organoids in vitro.

Keywords
Decellularized small intestine, intestine, extracellular matrix (ECM), intestinal organoids,
hydrogels, tissue-specific ECM, biomaterials

ii

Summary for Lay Audience
The small intestine is the organ in the body where most food digestion and nutrient
absorption takes place. It has been shown previously that stem cells give rise to all of the cell
types in the intestine, which is important for normal tissue turnover and healing.
Interestingly, these stem cells can be isolated from tissues and used to form “mini-intestines”
in a petri dish, called organoids. These organoids may allow researchers to develop models of
intestinal diseases for testing the effects of different drugs, or potentially could be used to
develop cell-based therapies for regenerative medicine applications. Currently, the only way
to form organoids is by encapsulating and culturing them within a jello-like material called
Matrigel, which contains essential proteins needed for the stem cells. However, Matrigel
is produced by mouse cancer cells, which means that the cells generated using this approach
cannot be used for clinical applications. The purpose of this study was to develop new
biomaterials to replace Matrigel for the growth of organoids, using proteins sourced from
intestinal tissues. There is evidence to support that such intestinal-derived materials could
support the survival and growth of stem cells, and help them to give rise to the other cell
types in the intestine. This thesis developed a new method for isolating intestinal-specific
proteins from mouse tissues. Further, these proteins were further processed to enable the
formation of gels that could be used to encapsulate cells. Cell culture studies confirmed that
the intestinal protein gels supported cell viability and the growth of mouse intestinal
organoids, similar to Matrigel. In addition, the effects of combining the intestinal proteins
with alginate, a natural gel that comes from seaweed, were explored to develop composite
materials that had more tunable mechanical properties. While the organoids were
successfully encapsulated and cultured within these composites, further studies are needed to
refine the conditions to promote organoid growth. Overall, this thesis contributed to the
development of promising new biomaterials that hold the potential to replace Matrigel as a
more clinically translational tissue-specific platform for studies of intestinal organoids.
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Chapter 1

1

Literature Review

1.1 Small Intestine
1.1.1 Structure and Function
The small intestine or small bowel is a luminal organ that connects the stomach and large
bowel. The length of the small intestine is variable, but on average is estimated to be
between 3 to 5 meters1. Functionally, the small intestine plays a vital role in the digestion
and absorption of nutrients1,2. This tube-shaped organ is comprised of three main
structural parts: the duodenum, jejunum, and ileum (Figure 1.1).

Figure 1.1. Anatomy of the small intestine. Diagram showing the parts of the small
intestine including the duodenum, jejunum, and ileum, and surrounding structures. Image
obtained with permission from Terese Winslow.
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The duodenum is the first and shortest segment of the small intestine. It connects to the
pylorus of the stomach at its proximal end and the jejunum at its distal end1–3. The role of
the duodenum includes receiving partially-digested food (chyme) from the stomach and
chemically digesting the chyme in preparation for absorption within the small intestine.
As the duodenum processes chyme, it also absorbs some nutrients, the most notable of
which is iron1–3. The jejunum, on the other hand, begins at the suspensory muscle of the
duodenum (ligament of Treitz) and forms the middle portion of the small intestine. The
jejunum is where important nutrients such as carbohydrates, protein, fat, and vitamins are
absorbed. These absorbed nutrients can then enter the bloodstream where they can be
further distributed to other organs within the body1–3. The ileum is the third and final
segment of the small intestine and is where remaining nutrients are absorbed including
vitamin B12 and bile acids1–3.

1.1.2 Intestinal Cell Populations
The intestinal lining is comprised of a single cell layer of intestinal epithelial cells that
line the luminal surface. The lining itself is organized in a structure that includes
fingerlike projections called villi and invaginations known as crypts (Figure 1.2). The
epithelial cells play a vital role in the digestion of food and the absorption of nutrients, as
well as protecting the human body from infection4. Importantly, the epithelium
continually renews itself every 3-5 days, with new epithelial cells being produced by
stem cells, which are located at the base of the crypts1,3. Progenitor cells derived from
these stem cells give rise to subsets of cells that ultimately differentiate into either
secretory or absorptive epithelial cells as they migrate up the crypt-villus axis1–3. The
older epithelial cells undergo cell death and are brushed off into the intestinal lumen3.
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Figure 1.2. The structure of the intestinal epithelium. Stem cells located at the base of
the crypts, surrounded by Paneth cells, mesenchymal cells, and an extracellular matrix
(ECM), ultimately give rise to daughter cells. Daughter cells (transit-amplifying cells)
differentiate into either absorptive (enterocytes) or secretory (Paneth, enteroendocrine,
goblet, and tuft cells) cell types and migrate along the crypt-villus axis. Eventually, older
cells at the tip of the villi undergo cell death and are brushed off into the lumen. The
image was created in BioRender.com.
Within the epithelium, there are several cell types present including enterocytes, goblet
cells, Paneth cells, endocrine cells, tuft cells and intestinal stem cells (ISCs). Enterocytes
are columnar cells that primarily have an absorptive function for nutrients5–7. Goblet cells
are columnar-shaped cells that secrete mucus to lubricate the intestinal wall for ease of
passage of food and protection from digestive enzymes and pathogens5. Paneth cells are
highly specialized cells specific to the small intestine, which provide niche factors and
signals necessary for ISC homeostasis within the crypt base, and secrete antimicrobial
peptides that protect against pathogens1,2,4,5. Endocrine cells can be found along the
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crypt-villus axis of the intestinal mucosa. Their main function involves secreting
hormones and releasing them into the bloodstream upon stimulation6. Tuft cells, also
known as brush cells, are found along the crypt-villus axis. Although they act as
chemosensory cells which can sense luminal content, their exact role in homeostasis is
not fully understood8,9. ISCs reside at the crypt base alongside Paneth cells, and serve to
give rise to all epithelial cells in the intestine. The intermediate daughter cells (transitamplifying cells) derived from the ISCs proliferate and migrate along the crypt-villus
axis, where they can differentiate into the different cell types of the intestine7,10. To
maintain their self-renewal and differentiation potential, ISCs are surrounded by a
cellular and physical niche that includes both epithelial and mesenchymal cell
populations distributed throughout the intestinal extracellular matrix (ECM)7.

1.1.3 Intestinal Extracellular Matrix
The ECM of the small intestine is a complex network of proteins and polysaccharides
that forms the supporting structure for the intestinal epithelium while also providing
essential biochemical cues7. The ECM surrounding the intestinal crypts incorporates
numerous bioactive proteins including laminin, various types of collagen, proteoglycans,
and fibronectin7.
Collagens: Collagen is the most abundant protein in the body and is the primary
structural protein in the ECM11. Collagen’s triple-helical structure allows it to assemble
into molecular complexes such as networks, which provide structural support to the
ECM11–13. In the healthy small intestine, the collagen fibers are organized in a cross-cross
pattern14. In addition to the structural role of collagen, collagens in the ECM are also
known to play bioactive roles by regulating cell adhesion, cell migration, and directing
tissue development12. Collagen subtypes I, III, IV, and VI are found well distributed
throughout the ECM of the small intestine7. Studies suggest that collagen VI is a key
regulator of the microenvironment for intestinal epithelial crypt cells7,15. Collagen VI is
known to interact with type IV collagen found in the basement membrane that is in direct
contact with the intestinal epithelial cells. Abnormalities in the structure and distribution
of collagen fibers can occur in intestinal diseases14. Changes in the collagen content
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within tissues can impact tissue stiffness, which in turn can regulate cellular processes
including growth factor signaling and cytoskeletal contractility16–18.
Laminin: Laminin is an abundant glycoprotein found in the ECM of the intestinal crypts,
and plays an important role in regulating intestinal epithelial cell function7,19. This crossshaped molecule is made up of three polypeptide chains that allow for the formation of
self-assembled laminin networks20. Laminin can also interact with other ECM molecules,
such as collagen20. Laminin expression during early development suggests that it plays an
important role in cell differentiation in the epithelium21. Cells interact with laminin
through cell surface receptors known as integrins. Functionally, interactions with laminin
can modulate cellular activities including cell adhesion, migration, and survival21,22.
Alterations in laminin distribution and expression have been detected in various
pathologies of the intestine, emphasizing its importance in regulating cell function7,23.
Fibronectin: Fibronectin is an ECM glycoprotein found in all tissues that is an important
mediator of cell-matrix interactions. Fibronectin assembles into a fibrillar matrix through
cell-mediated processes18. The fibronectin fibrils can form linear or branched networks
that function to interconnect neighbouring cells, and it has both structural and functional
roles within tissues18. Fibronectin has domains that allow it to interact with other proteins
and glycosaminoglycans found within the ECM, as well as with cell surface
receptors7,24,25. Intestinal fibronectin is secreted by both fibroblasts and epithelial
cells26,27. Similar to other basement membrane proteins, irregular deposition patterns of
fibronectin have been correlated with various intestinal pathologies7,26,28.
Glycosaminoglycans: Glycosaminoglycans (GAGs) are carbohydrate molecules that
have important biologic functions. GAGs are covalently attached to core proteins to form
proteoglycans12 and can interact with other proteins to regulate cell signaling, cell
proliferation, and angiogenesis29,30. GAGs can be divided into two main types: (i) nonsulphated GAGs, such as hyaluronic acid, or (ii) sulphated GAGs (sGAG), such as
chondroitin sulphate and heparan sulphate30. GAGs are important for both lubrication and
structural support within the intestinal ECM30. In the small intestine, heparan sulphate
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and hyaluronic acid play a role in signaling pathways that regulate embryonic
development, tissue homeostasis, intestinal crypt homeostasis, and inflammation31–35.
Overall, the intestinal ECM is essential for the growth of epithelial cells in vivo. More
recently, it has been discovered that the ECM can be used to support the growth of ISCs
in vitro36.

1.2 Intestinal Organoid “mini-guts”
1.2.1

Overview of Intestinal Organoids

Over the last decade, an increasing number of studies have grown either single or clusters
of epithelial cells in substances that contain components of the basement membrane,
primarily Matrigel, to form tissue-resembling structures known as organoids. Culturing
within a three-dimensional (3D) microenvironment that mimics the in vivo milieu
provides cells with cues that stimulate their self-organization to form “mini-guts”, in
contrast to the monolayer culture that is typically observed when the cells are expanded
in two-dimensional (2D) cell culture models37. Organoids recapitulate features of the
native small intestine from an anatomic, cellular, and functional basis38. More
specifically, intestinal organoids contain a functional lumen that is surrounded by a
polarized epithelial layer (Figure 1.3). This layer has all of the cell types of the
epithelium organized with similar proportions of cell types as what is found in the native
organ39. In vitro studies have evaluated the use of intestinal organoids for testing
epithelial permeability to a variety of molecules, validating their use as a potential in
vitro drug transport model40. Organoids have also been applied to model intestinal
diseases caused by inflammation or physical injuries, such as inflammatory bowel
disease, Crohn’s disease, short bowel syndrome, and colorectal cancer40.
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Figure 1.3. Intestinal organoid morphology. An epithelial monolayer with budding
crypt-like domains surrounds a central lumen. Stem cells and differentiated cell types
found along the epithelial monolayer eventually undergo cell death and are brushed off
into the lumen. Image was created in BioRender.com.

1.2.2

Current Methods for Generating Organoids

Intestinal organoids can be derived from primary intestinal tissue or from pluripotent
stem cells40.
Primary Tissue-Derived Organoids: Organoids derived from primary intestinal tissues
were first described by Hans Clevers’ group in 200936. More specifically, the authors
described a culture system in which a single stem cell characterized by its expression of
leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5), was able to give rise
in vitro to crypt-villus structures, without the addition of a mesenchymal component36.
The initial protocol that was published by Sato et al. described a methodology that could
be used to isolate mouse intestinal crypts and subsequently culture them to form
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organoids41. In this system, primary intestinal tissues were embedded in Matrigel and
cultured in media supplemented with growth factors, including R-Spondin-1, epidermal
growth factor (EGF), and Noggin. These factors are a wingless-related integration site
(Wnt) signaling agonist, an inducer of intestinal proliferation, and a bone morphogenic
protein (BMP) inhibitor, respectively36,42–44. These adult stem cell-derived intestinal
organoids are characterized by an epithelial monolayer that surrounds a hollow lumen.
The epithelial cells in these organoids are known to contain all of the cell types found in
vivo, including stem cells and cells important for the ISC niche such as Paneth cells36,45.
In addition to developing this culture system for the mouse small intestine, researchers
have further adapted these protocols to grow organoids from human small intestine and
both human and mouse colon36,41.
Pluripotent Stem Cell-Derived Organoids: Building on the organoid cultures established
by the Clevers group, new protocols for generating human intestinal organoids from
human embryonic and induced pluripotent stem cells have also been developed46,47.
Using various growth factors, robust processes have been established to direct the
differentiation of human pluripotent stem cells (hPSC) into intestinal cells46. When
cultured within Matrigel in the presence of inductive growth factors that promote cell
differentiation, the pluripotent stem cells can form 3D organoids that have a polarized
epithelium that contains the various cell types found in vivo39,46,47. In contrast to
organoids derived from primary intestinal tissues, these pluripotent stem cell-derived
organoids also incorporate a mesenchymal component that contributes to the signaling
required for organoid growth39.

1.3 Biomaterials for Intestinal Cell Culture and Delivery
1.3.1

Design Requirements

The formation of organoids requires the use of cell-supportive scaffolding materials that
can encapsulate cells with high viability, forming a 3D niche in which the cells can
adhere, grow, and differentiate48. The bioscaffold should provide biochemical cues that
mimic the native ECM and needs to promote ISC proliferation and lineage-specific
differentiation, while allowing the cells to self-organize into the organoid structures48. In
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addition to bioactivity, the physical properties of the scaffolds can be important for
generating organoids through ISC expansion49. In particular, the stiffness and porosity of
the materials can affect the growth and differentiation of the ISCs50. Therefore, a material
with tunable mechanical properties must be considered for an ISC culture system.
Furthermore, an initial qualitative assessment of organoid growth is typically achieved by
brightfield imaging of the 3D scaffold that encapsulates the organoids36,50. Therefore,
having an optically clear or transparent material is vital for imaging at different depths by
microscopy. As such, studies have focused on the use of natural biomaterials, which offer
the advantage of providing innate bioactive cues, along with synthetic or semi-synthetic
materials that have more tunable mechanical properties48–50.

1.3.2

Matrigel

Matrigel is a soluble basement membrane protein extract derived from Engelbreth–
Holm–Swarm mouse sarcoma cells51. Matrigel has been used for decades in a variety
of cell-culture applications, as it supports cell morphogenesis, differentiation, and
promotes organoid assembly. Matrigel is composed primarily of four major ECM
proteins: laminin, collagen IV, entactin, and heparan sulphate. In addition to providing a
bioactive microenvironment that regulates cell behavior, these proteins play a structural
role in Matrigel, allowing it to form a hydrogel at temperatures ranging from 22 to 37
°C51,52. To date, most ISC cultures have relied on Matrigel, and it is currently the “gold
standard” material for promoting intestinal organoid growth48–50. Matrigel, however,
has many limitations including that it is tumour-derived, its composition is ill-defined, it
lacks tunability in its mechanical properties, and there can be batch-to-batch variability
that may lead to reproducibility issues in cell culture experiments51,52. These limitations
have led scientists to work on developing alternative scaffolds for intestinal cell culture
and delivery.

1.3.3

Hydrogels

Hydrogels are 3D networks of hydrophilic polymers which have the ability to swell and
retain large quantities of water without disrupting their structure due to polymer
crosslinking53. Hydrogels can be formed physically or chemically, where physical gels
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are stabilized through physical interactions and entanglement of the individual polymer
chains, while chemical hydrogels are formed through covalent bonds53,54. Hydrogel
crosslinking can be stimulated through a range of physical and chemical mechanisms
including changes in temperature, pressure, and/or pH, exposure to light, or through their
own chemical composition53.
Hydrogels derived from natural materials, including components of tissues, are promising
for cell culture and delivery applications due to their innate bioactivity and the fact that
they can often be degraded through cell-mediated mechanisms55. Relative to hydrogels
derived from synthetic polymers such as polyglycolic acid and polyethylene glycol
(PEG), naturally-derived hydrogels tend to have weaker and less easily tuned mechanical
properties but contain natural bioactive cues that help to support cell survival and
function55. In the intestinal stem cell field, a variety of hydrogels and hydrogel
composites have been investigated for applications in organoid growth and tissue
regeneration56–59. In particular, alginate has been widely-investigated as a biomaterial due
to its capacity to reversibly encapsulate cells and support their long-term viability in
culture60. In addition, there is growing interest in the application of ECM-derived
hydrogels sourced from decellularized small intestine to generate tissue-specific
platforms, which will be discussed in detail in the next section.
Alginate Hydrogels: Alginate is a natural polymer derived from the walls of brown
seaweeds, which is a polysaccharide comprised of β-(1–4) linked d-mannuronic acid and
β-(1–4)-linked l-guluronic acid units61. Alginate possesses a range of desirable
characteristics as a cell culture platform including controllable porosity, ease of gelation,
and biodegradability60. Alginate crosslinks under mild conditions with the addition of
divalent cations such as calcium and has been shown to support the viability of
encapsulated cell populations59–61. Additionally, the crosslinking of alginate can be
reversed to release cells with the use of chelating agents such as sodium citrate62.
Alginate gels have previously been used in a range of applications including as cell
culture platforms, wound dressings, drug delivery systems, and as an injectable gel for
tissue-engineering applications60,63. One study by Capeling and colleagues demonstrated
the use of alginate to support the growth of hPSC-derived intestinal organoids59. More
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specifically, this study showed that human intestinal organoids grown on alginate were
similar to human intestinal organoids grown on Matrigel. Specifically, hPSCs were first
cultured in Matrigel before being encapsulated within alginate and crosslinked with
calcium chloride. Using a LIVE/DEAD stain, they assessed spheroid viability on days 3
and 7 using different concentrations of alginate, and found that spheroids grown in 1%
and 2% alginate remained nearly 100% viable, similar to Matrigel. However, they
found that the number of spheroids that gave rise to intestinal organoids on day 28 postencapsulation was significantly lower in all alginate concentrations tested compared to
Matrigel. Histological and immunohistochemical analyses of the intestinal organoids at
28 days post-encapsulation revealed that the organoids grown in alginate expressed
similar epithelial cell markers and proliferative cell markers with similar frequency to
those grown in Matrigel. Though hPSCs are distinct from primary mouse tissue, this
study demonstrated promising evidence for the use of alginate-based platforms for the
culture of intestinal cells.

1.4 Decellularized Tissue Bioscaffolds
1.4.1

Overview of Tissue Decellularization

Decellularization is a process that aims to isolate the ECM from native tissues and organs
that can be used to develop tissue-specific bioscaffolds for cell culture and delivery64.
The process involves the removal of cellular components that would induce an
immunogenic response, while preserving the structure and composition of the native
ECM as much as possible65. The extraction of cells requires methods that are unique to
each tissue, tailored based on the physical and biochemical properties of the specific
source66. The effectiveness of various methodologies used for decellularization depends
on factors including the tissue cellularity, density, and lipid content67. Over the past two
decades, virtually all tissue types have been decellularized including, but not limited to,
the small intestinal submucosa, urinary bladder, adipose tissue, and bone68–71. Typically,
decellularization protocols use a combination of physical, chemical, and enzymatic
treatments selected to extract cells and cellular debris, while minimizing alterations to the
structural components of the ECM66.
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Physical methods of tissue decellularization: Physical treatments may include agitation,
the application of pressure, or freeze-thawing to promote cell lysis through the formation
of ice crystals. All of these treatments result in the disruption of cell membranes and can
assist in the removal of cell contents64,66,67,72. Though physical processing may be
beneficial, these methods alone are not sufficient to extract cell contents from the tissues,
and they are therefore commonly combined with chemical treatments to wash away the
resultant cellular debris66.
Chemical methods of tissue decellularization: Chemical treatment varies depending on
the specific tissue undergoing decellularization. Hypertonic and hypotonic solutions are
often used to lyse the cells within tissues through osmotic shock and are commonly used
in combination with chelating agents such as ethylenediaminetetraacetic acid (EDTA) to
disrupt cell-cell and cell-ECM interactions66. Treatment using ionic or non-ionic
detergents is commonly employed to further solubilize cell membranes. Non-ionic
detergents such as Triton-100X are thought to be favorable as they tend to have less of an
impact on protein structure while still disrupting lipid-lipid and lipid-protein
interactions66. Ionic detergents, such as sodium dodecyl sulphate (SDS) or sodium
deoxycholate, are known to be stronger chemical agents that can be more effective at
disrupting cell membranes, but can also cause changes in the native protein structure and
composition66,72. Detergent treatments can also extract more soluble ECM components,
including basement membrane constituents such as laminin, as well as GAGs73. In
general, detergents need to be extensively washed away to avoid potential cytotoxic
effects when the resultant bioscaffolds are applied in downstream studies74.
Enzymatic methods of tissue decellularization: Enzymatic methods are often included in
decellularization protocols, most typically proteases such as trypsin, nucleases such as
deoxyribonuclease (DNase) and ribonuclease (RNase), and lipases66. Trypsin is a widely
used enzyme in decellularization protocols as it disrupts integrin binding and releases
cells from the ECM. However, prolonged exposure to trypsin can result in damage or loss
of key ECM components including GAGs and laminin66. Residual nucleic acids
remaining following cell lysis from physical and chemical treatments can be effectively
degraded using nucleases such as DNase and RNase, and these are frequently
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incorporated in decellularization protocols64–67,72,75. Enzymes, similar to detergents, need
to be carefully rinsed away at the end of the tissue digestion process to avoid overdigestion or potential off-target effects.

1.4.2

Characterization of Decellularized Tissues

Following decellularization, it is important to characterize the tissues to confirm the
removal of cellular components and the retention of key ECM components. A variety of
methods can be used to assess and characterize decellularized tissues, however, there
remains a need for improved guidelines on the amount of residual cellular debris that is
acceptable when applying the scaffolds for cell culture or delivery76,77.
Tissue decellularization is often evaluated using a combination of histological,
immunohistochemical, and biochemical analyses. Nuclear content is often measured to
detect the presence of residual cells and DNA78,79. Cell nuclei can be visualized in tissue
sections through methods such as 4’,6-diamidino-2-phenylindole (DAPI) staining, and
double-stranded DNA (dsDNA) content can be quantified using the Quant-iTTM
Picogreen kit80,81. Aside from cellular content, the assessment of the structure and
composition of the ECM is also important. Immunohistochemistry (IHC) can be used to
visually assess the presence and distribution of ECM components in decellularized
tissues76. Total collagen and sGAG content are often quantitatively assessed via the
hydroxyproline assay and dimethylmethlyene blue (DMMB) assay, respectively82–84.
Furthermore, picrosirius red staining can be performed to visualize the structure of the
collagen fiber network, and toluidine blue staining is commonly employed to visualize
the presence of GAGs81,85. More recently, techniques such as high-throughput mass
spectrometry have allowed for a more detailed proteomic analysis of decellularized
tissues86,87.

1.4.3

Small Intestine Decellularization Protocols

With an interest in developing scaffolds for applications in intestinal tissue engineering,
several groups have developed decellularization protocols for the small intestine and
created bioscaffolds for intestinal cell culture85. A variety of animal models have been
used as tissue sources, including rats, mice, and pigs56,81,85. Attempts have been made to
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preserve the tissue architecture by leaving the entire intestine intact during processing,
while in other cases, the tissue was minced to provide greater exposure to the
decellularization agents and enhance cell removal56,88. Most decellularization protocols
targeting the intestine have used harsh anionic detergents such as sodium deoxycholate or
SDS. As discussed above, these detergents are effective at extracting cells, however, their
use is also commonly associated with the loss of GAGs and denaturation of ECM
proteins56,67,74,81,85,88,89. A smaller number of studies have employed non-ionic detergents
such as Triton X-100, which have been shown to better preserve the ECM ultrastructure,
while effectively removing cellular content67,74,81,90. In 2012, one study aimed to develop
an intestinal decellularization protocol using a detergent-enzymatic treatment with rat
intestine85. More specifically, the protocol used intact segments of the native intestine,
which were treated with a solution of 4% sodium deoxycholate, followed by DNase.
Following a single cycle of treatment, there was a significant reduction in DNA content
and increased collagen content. With repeated treatment cycles, there was greater cell
extraction but also a progressive loss of GAGs, along with disruption of the tissue
ultrastructure based on scanning electron microscopy.
A study conducted by Oliveira et al. compared the use of different decellularization
agents for mouse small intestine81. In particular, the study compared the use of varying
concentrations of SDS (0.1% to 0.6%) or Triton X-100 (0.1% to 6%). Following
treatment with SDS or Triton X-100 for 24 hours, they characterized cell removal and the
retention of collagen and proteoglycans. Both methods significantly reduced the DNA
content of the tissue as compared to native tissue controls. DNA quantification did not
reveal any significant difference in levels of DNA between SDS-treated (8.63±4.06 ng of
DNA per mg of dry weight of decellularized tissue) and Triton X-100-treated
(9.70±14.05 ng/mg) small intestines. Semi-quantitative analysis of collagen fibers by
picrosirius red staining intensity revealed that the SDS-treated intestines overall had
significantly less collagen staining compared to native controls, whereas Triton X-100treated groups showed similar staining intensities to the native controls. Semiquantitative analysis of proteoglycan content determined by alcian blue staining intensity
revealed no significant differences between the tissues treated with SDS or Triton X-100
compared to the native controls. All treated groups had alterations in the structural
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organization of the ECM based on scanning electron microscopy images. However,
samples treated with Triton X-100 were found to have a more well-preserved ECM
structure as compared to SDS treated groups.
In another study in 2014, porcine small intestinal submucosa was decellularized using
combined treatment with 1% SDS and 1% Triton X-10074. This protocol reduced the
dsDNA content relative to native tissue samples (~64% decrease). However, cell culture
studies using primary human esophageal smooth muscle cells showed reduced metabolic
activity when the cells were cultured with the scaffolds, which was attributed to cytotoxic
effects of residual detergent. This study additionally investigated the use of peracetic acid
to decellularize the intestinal submucosa, but found there was no significant reduction in
DNA content in the processed tissues relative to native controls74.
Finally, a study in 2019 by Hans Clevers’ group decellularized porcine small intestine
using 4% sodium deoxycholate for 4 hours, followed by a washing step in Milli-Q water
for 24 hours, and then DNase-I treatment for 3 hours56. Following decellularization, DNA
was quantified using a DNA Mini Kit and measured using a Nanodrop. DNA content was
significantly reduced in the decellularized tissue (~25 ng/mg) compared to native controls
(~150 ng/mg). They further processed their ECM into a hydrogel and quantified their
collagen and glycosaminoglycan contents. The relative collagen content in the
decellularized samples (~27.81 μg/mg) was significantly higher compared to the native
tissue samples (~13.92 μg/mg). Additionally, the glycosaminoglycan content was not
significantly different in the decellularized samples (~0.51 μg/mg) as compared to native
controls (~0.91 μg/mg).

1.4.4

ECM-Derived Scaffold Formats

ECM-derived bioscaffolds have been generated in a range of formats including foams,
microcarriers, coatings, whole-organ scaffolds, and hydrogels, using a variety of different
tissue sources to generate platforms tuned for cell culture and/or delivery70,76,77,91,92. In
the context of the intestine, one study using decellularized rat small intestine attempted to
preserve the entire small intestine-tissue architecture to generate 3D scaffolds for
intestinal regeneration purposes85. Their tubular decellularized intestine was seeded with
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amniotic fluid stem cells labeled with iron oxide particles by placing the labelled cells
directly into the scaffold lumen. The researchers used magnetic resonance imaging (MRI)
to investigate the distribution of the cells and found that cells were attached to the villus
structure of the decellularized intestine. Additionally, using a chicken chorioallantoic
membrane assay, they observed vessel growth towards their implanted decellularized
tissues, suggesting their intestinal ECM may have pro-angiogenic effects85. Taking a
similar approach, another study decellularized the porcine ileum and its associated
vasculature, leaving the entire tissue architecture intact89. When their scaffolds were
implanted subcutaneously in rats, they observed host cell infiltration starting at 2 weeks
post-implantation and reported that there were no signs of an adverse immune response at
up to 8 weeks post-implantation89.
While preserving the 3D tissue architecture may be favorable for the design of tissueengineered intestinal replacements, ECM-derived hydrogels that incorporate the complex
composition of the ECM within a more tunable format that allows cell encapsulation are
more appropriate as platforms for deriving intestinal organoids. As such, there is growing
interest in the use of ECM-derived hydrogels for gastrointestinal organoid cultures and as
injectable cell delivery systems for in vivo tissue regeneration applications91,93. Pepsin is
the most widely-used enzyme for solubilizing tissue-derived ECM to generate peptide
solutions that can be used to fabricate ECM hydrogels57. Hydrogels have been
successfully produced from pepsin digests from a wide range of tissue sources including
bone, cartilage, adipose tissue, and gastrointestinal tissues56,57,94–98. Notably, the pepsin
digestion protocol must be carefully refined based on the properties of the specific tissue
of interest. The enzymatic activity of pepsin and its effects on the ECM structure and
composition are influenced by the digestion time, pH, concentration, and physical
agitation57. Although pepsin cleaves proteins in many locations, protocols can be
developed such that collagens are cleaved in locations where collagen fibril aggregates
will unravel, without disrupting the collagen triple-helical structures required for ECM
self-assembly into a hydrogel56,57,99. While pepsin digestion will alter the ECM structure
and composition, hydrogels derived from pepsin-digested ECM have been shown to have
bioactive effects on cells56.
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Some studies have used collagen-based gels for culturing intestinal cells93-95. For
instance, a study in 2013 used hydrogels comprised of type I porcine tendon collagen to
culture primary mouse small intestinal cells, both with and without the coculture of
supporting intestinal subepithelial myofibroblasts (ISEMF), and compared to Matrigel
controls100. The collagen gels were able to support the growth of the murine small
intestinal cells without coculture with ISEMF. However, morphological differences,
particularly the lack of budding structures in organoids grown in collagen compared to
Matrigel were observed when the organoids were analyzed at 1 to 13 days post-culture.
Additionally, epithelial expansion after 1 week in culture was significantly higher in
Matrigel as compared to the collagen gels. However, the collagen-based hydrogels
were able to support the sub-culturing of the intestinal organoids for at least four
passages100.
Recently, Hans Clevers’ group investigated the use of ECM hydrogels derived from
decellularized porcine small intestine for culturing organoids from different endodermal
tissues including the small intestine, liver, stomach, and pancreas56. Following
decellularization, they solubilized their ECM using pepsin and subsequently used the
solubilized ECM to form hydrogels that self-assembled at 37 °C. Proteomic analyses
using mass spectrometry on the decellularized tissue prior to pepsin-digestion revealed
that 749 proteins of 1600 identified were derived from either the ECM or extracellular
exosomes. Additionally, fibrillar collagens such as types I, II, III, V and VI were the most
abundant proteins identified. The ECM proteins identified were then clustered based on a
publicly-available map of the human proteome, and they revealed a high degree of
similarity in the composition of their ECM to tissues of endodermal origin including gut,
pancreas, and liver. The porcine intestinal-derived hydrogels were shown to support the
growth and viability of both human and mouse intestinal cells, which were characterized
by brightfield imaging, histological analyses, as well as quantitative analyses of organoid
diameter, similar to Matrigel. However, the morphological quality of the human
intestinal organoids was decreased after multiple passages in the intestinal-derived
hydrogels.
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1.4.5

Cell-Instructive Effects of the ECM

The composition, structure, and biomechanical properties of the ECM establish a
microenvironment that regulates cell phenotype and function in a tissue-specific
manner77. Cells interact with the ECM through cell surface receptors including integrins,
which are proteins that facilitate cell-ECM adhesion103. Integrin binding can further
regulate signaling pathways leading to the modulation of gene expression in cells30,104. In
the context of the intestine, signaling regulated by integrin binding has been found to
affect the maintenance of ISCs and the differentiation of epithelial cells105,106. For
instance, β1 integrins have been implicated to be necessary for ISC proliferation by
mediating the Hedgehog signaling pathway in mice106. The Hedgehog pathway is also
involved in organogenesis and tissue repair in the intestine30. Basement membrane
proteins and integrins have also shown differential expression along the crypt-villus axis
in the human intestine107–109. For example, laminins with α1 heavy chains were found to
be associated with differentiated cells in the villi, whereas the α2 variants were associated
with the crypts104,107. Thus, the distribution of ECM components and integrin receptors in
the intestine are tissue-specific and ultimately affect the fate of intestinal cells.
Although the native composition within ECM-derived scaffolds can influence cell
behaviours via receptor-ligand interactions, degraded ECM products, termed matrikines,
provide another potential mechanism through which the ECM can regulate cell
behaviors77,110. Matrikines are generated through the enzymatic cleavage of extracellular
proteins and proteoglycans by matrix metalloproteinases (MMPs). The fragmented
molecules that are released as a result of proteolytic cleavage usually exert biological
activities that differ from those of their full-length counterparts110. Studies have shown
the production of matrikines to be associated with modulation of cell migration, adhesion,
recruitment, and differentiation77,111,112. Interestingly, matrikines generated from GAGs
have been shown to stimulate MMP production, which can subsequently act on
remaining GAGs and promote the release of sequestered growth factors77,110.
In addition to the biochemical properties of ECM-derived scaffolds, each tissue has
unique biomechanical properties that can also influence cellular behaviour113. Cells can
sense mechanical forces through the ECM through binding via integrins and formation of
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cell adhesion complexes, which can lead to the activation of signaling cascades that
influence cell adhesion, differentiation, and proliferation77,105,114. More specifically,
biomechanical properties have been shown to play a critical role in controlling the selfrenewal and lineage specification of ISCs102,107.
A study by Gjorevski et al. in 2016 investigated the effects of matrix stiffness on ISC
expansion102. The researchers encapsulated primary mouse ISCs in hydrogels composed
of PEG and an Arg-Gly-Asp (RGD) peptide commonly found within ECM proteins.
They quantified colony-forming efficiency and found that ISC proliferation was poor in
matrices with soft stiffness (300 Pa), whereas ISC expansion was promoted when stem
cells were encapsulated in hydrogels of intermediate stiffness (1.3 kPa). To investigate
the mechanisms through which mechanical properties affect ISC expansion, they
assessed the localization of yes-associated protein 1 (YAP) within the ISCs expanded in
the hydrogels of varying stiffness. YAP is an effector of the hippo signaling pathway
required for ISC self-renewal and expansion, and plays a role in cellular
mechanosensing30. They found that YAP was primarily localized to the cytoplasm in the
organoids encapsulated within soft hydrogels, whereas higher stiffness (1.3 kPa)
hydrogels had higher nuclear localization after 1 day in culture. Thus, matrix stiffness
was able to control ISC expansion through YAP-dependent mechanisms.
Despite the initial increase in YAP activity, the study found that the proportion of ISCs
with YAP activity significantly dropped over time, leading them to investigate a dynamic
matrix that could soften over time102. Instead of a static PEG hydrogel with a stable
polymer (sPEG), they used a dynamic hydrolytically-degradable polymer (dPEG) that
could soften over time. With the addition of RGD and laminin-111 in their hydrogels,
they found that budding organoids could form in the dynamic matrices that softened over
time and found differentiated cells and higher YAP activity in softening hydrogels
compared to ones that remained stiff over time. Overall, the study demonstrated the
importance of mechanical properties as they can affect signaling pathways necessary for
both ISC expansion and differentiation. Other physical 3D architectural properties of the
ECM can also influence cell behaviour105. In particular, parameters such as scaffold
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porosity and surface topography of ECM-scaffolds can modulate cell-cell and cell-ECM
interactions, and the binding of cells to the scaffolds77,115.

1.5 Project Overview
1.5.1

Rationale

Currently, the “gold standard” for culturing intestinal organoids is Matrigel, an ECMderived product from mouse sarcoma cells. Matrigel can support cell attachment and
direct stem cell function including survival, proliferation, and differentiation. The need to
culture in Matrigel, however, remains a barrier to understanding the stem cell niche and
characterizing its growth-promoting matrix proteins. The fact that Matrigel is derived
from mouse cancer cells limits the clinical utility of organoids grown using this culture
system and Matrigel could not be applied as an injectable cell delivery platform for
therapeutic applications in humans. Recognizing these limitations, biomaterials derived
from tissue-specific ECM represent a promising alternative for developing improved
platforms for ISC culture and delivery. Specifically, hydrogels incorporating
decellularized small intestine have the potential to enable cell encapsulation with high
viability, similar to Matrigel, while providing tissue-specific cues that may help to
direct stem cell proliferation and differentiation.

1.5.2

Hypothesis

The overall objective of this project is to develop hydrogel biomaterials for cell
encapsulation that incorporate intestinal-derived ECM that can be used in place of
Matrigel for the culture of intestinal stem cell-derived organoids. We hypothesized that
the intestinal-derived ECM would provide cell-instructive cues that would modulate the
response of encapsulated cell populations and promote intestinal organoid growth.

1.5.3

Specific Aims

Aim 1: To establish a decellularization protocol for mouse small intestine and
characterize the resultant decellularized tissue.
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Aim 2: To develop 3D hydrogels comprised exclusively of decellularized mouse small
intestine and compare the response of encapsulated cell populations relative to Matrigel
controls.
Aim 3: To develop composite alginate-based hydrogels incorporating pepsin-digested
decellularized mouse small intestine and confirm that the ECM has bioactive effects on
encapsulated cell populations.
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Chapter 2

2

Materials and Methods

2.1 Intestinal Decellularization
Adult male and female C57BL/6 mice (2–4 months in age) were euthanized by CO2
overdose and the entire small intestine was surgically extracted by cutting at the pyloric
sphincter and the ileocecal valve and subsequently transferred into Hank’s balanced salt
solution (HBSS). The intestines from ~35 to 45 mice were pooled together to create large
batches and these were then perfused with HBSS using a needle and syringe to remove
the intestinal contents. Next, the intestines were cut longitudinally with a scalpel, and
scraped with a glass slide to remove any residual intestinal contents. Finally, the tissues
were minced into ~2 mm pieces using surgical scissors.
For decellularization, all solutions were supplemented with 1% (v/v) antibioticantimycotic (ABAM) (Invitrogen, ON, Canada) and 0.27 mM phenylmethylsulfonyl
fluoride (PMSF) (excluding enzymatic digestion steps) and all incubation steps were
performed in a 100 mL solution volume at 37 oC under agitation on a Labnet 311DS
orbital shaker control system (Labnet International, Inc., NJ, United States) at 120 rpm.
The tissues were subjected to three freeze-thaw cycles (-80 oC/ 37 oC, thawing at 120 rpm
for 1-2 hours) in 10 mM tris (hydroxymethyl)aminomethane (Tris) and 5 mM
ethylenediaminetetraacetic acid (EDTA) in deionized water (dH2O) (pH 8.0). Solutions
were replaced between each freeze/thaw cycle. After the third thaw, the samples were
transferred into 50 mM Tris in dH2O supplemented with 1% (v/v) Triton X- 100 (pH 8.0)
for 24 hours. The samples were then rinsed three times for 20 minutes each in Sorenson’s
phosphate buffer (SPB) rinsing solution comprised of 0.55 M sodium phosphate dibasic
heptahydrate (Na2HPO4•7H2O) and 0.17 M potassium phosphate (KH2PO4) in dH2O (pH
8.0). The samples were then enzymatically digested for 6 hours in SPB digest solution
comprised of 0.55 M Na2HPO4·7H2O, 0.17 M KH2PO4, and 0.049 M magnesium
sulphate heptahydrate (MgSO4·7H2O) in dH2O (pH 7.3) supplemented with 300 U/mL
deoxyribonuclease (DNase) Type II (from bovine pancreas) and 20 U/mL ribonuclease
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(RNase) Type III (from bovine pancreas). Next, the samples were incubated in 1% (v/v)
Triton X-100 in 50 mM Tris buffer (pH 8.0) for 24 hours. Finally, the samples were
rinsed three times for 20 minutes in SPB rinsing solution, followed by two rinses in dH2O
for 30 minutes, and then frozen at -80 oC and lyophilized using a Labconco Freezone 4.5
lyophilizer (Labconco, MO, United States) for 48 hours.

2.2 Compositional Characterization of the Decellularized
Small Intestine
2.2.1

Histology

Native and decellularized small intestine (DSI) samples (n=3 cross-sections/batch, N=3
independent decellularization batches) were embedded in Tissue-Tek OCT compound
(Sakura Finetek, CA, United States) and immediately placed on dry ice in preparation for
cryosectioning (7 μm sections) with a Leica CM3050 S cryostat (Leica Microsystems
Inc., ON, Canada). Samples were then fixed in acetone at -20 °C for 10 minutes,
followed by three rinses in phosphate buffered saline (PBS) for 2 minutes each. Sections
were stained with either (i) hematoxylin and eosin (H&E) to visualize the cells within the
surrounding extracellular matrix (ECM), (ii) 4’,6-diamidino-2-phenylindole (DAPI) in
fluoroshield mounting medium (ab104139, Abcam) to visualize cell nuclei, (iii)
picrosirius red to visualize collagen, or (iv) toluidine blue to visualize
glycosaminoglycans (GAGs), following standard protocols. DAPI images were obtained
using an EVOS FL fluorescence microscope (Thermo Fisher Scientific Inc., ON,
Canada). H&E and toluidine blue staining was visualized using an EVOS XL Core
microscope (Thermo Fisher Scientific Inc., ON, Canada), and the picrosirius red stained
samples were imaged using a Nikon Optiphot polarizing microscope (Nikon Instruments
Inc., NY, United States).

2.2.2

Biochemical Assays

Biochemical assays were performed to assess the composition of the DSI relative to
native tissue controls. More specifically, the PicoGreen® assay was used to quantify the
double-stranded DNA (dsDNA) content, collagen content was quantified using the
hydroxyproline assay, and the dimethylmethyleneblue assay (DMMB) was used to
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quantify the sulphated GAG (sGAG) content (N=7 independent decellularization batches
for all assays).
Lyophilized samples were finely minced using surgical scissors in preparation for
analysis. Ten mg of minced sample was then digested in 1 mL of Tris-EDTA (TE) buffer
supplemented with 600 U Proteinase K (Qiagen, Germany) overnight at 56 oC in a
HERATherm Thermomixer oven at 1200 rpm (Thermo Fisher Scientific Inc., ON,
Canada). The enzyme was inactivated by heating the samples to 92 oC for 5 minutes
while under agitation.
PicoGreen assay: Tissue samples were prepared using the DNeasy Blood & Tissue Kit
(Qiagen, Germany), following the manufacturer’s protocols. dsDNA content within the
native and decellularized tissue samples was quantified using the Quant-iTTM
PicoGreen® assay (Molecular Probes, Ontario). An eight-point standard curve ranging
from 0 ng/mL to 500 ng/mL was prepared by serial dilution of the λ-DNA standard
provided with the PicoGreen® kit in TE buffer. Fifty μL of each sample (diluted 1:20 for
decellularized samples or 1:300 for native samples in TE buffer) was combined with 150
μL of Quant-iT™ reagent and fluorescence was read using a CLARIOstar® microplate
reader, according to the manufacturer’s instructions. The dsDNA concentration was
normalized to the dry weight of each sample.
Hydroxyproline assay: A hydroxyproline assay was used to quantify the hydroxyproline
concentrations within the decellularized and native tissue samples, as a measure of total
collagen content. Briefly, 100 μL of the proteinase K-digested samples were hydrolyzed
in 100 μL of 12 N hydrochloric acid at 110 oC overnight and neutralized with 100 μL of
6 N sodium hydroxide. One hundred μL of dH2O was added and the samples were
centrifuged at 400 x g for 1 minute. The supernatant was analyzed as previously
described84. Absorbance was read using a CLARIOstar® microplate reader at 560 nm.
The hydroxyproline concentration was normalized to the dry weight of each sample.
Dimethylmethylene blue assay: The DMMB assay was used to quantify the sGAG
content following decellularization in comparison to native tissue samples, as previously
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reported84. Absorbance was read using a CLARIOstar® microplate reader at 525 nm. The
sGAG concentration was normalized to the dry weight of each sample.

2.2.3

Immunohistochemical Staining

Native and decellularized intestine samples (n=3 cross-sections/batch, N=3 independent
decellularization batches) were embedded in Tissue-Tek OCT compound (Sakura
Finetek, CA, United States) and immediately placed on dry ice in preparation for
cryosectioning, as described above. The sections were fixed in acetone for 10 minutes at 20°C and blocked in 10% goat serum in tris-buffered saline with 0.1% tween (TBST) for
1 hour at room temperature. The sections were then incubated overnight at 4°C with
primary antibodies against collagen type I (dilution 1:100 in TBST with 2% BSA,
ab34710, Abcam, ON, Canada), collagen type IV (dilution 1:100, ab6586, Abcam),
fibronectin (dilution 1:150, ab23750, Abcam), and laminin (dilution 1:200, ab11575,
Abcam). Next, an anti-rabbit secondary antibody conjugated to Alexa Fluor 594 (dilution
1:200, ab150080, Abcam) was added and the samples were incubated for 1 hour at room
temperature. Samples were then mounted in fluoroshield mounting media with DAPI. All
samples were prepared together and negative controls with the absence of primary
antibodies were included for both native and decellularized samples. Images were
acquired with an EVOS FL fluorescence microscope (Thermo Fisher Scientific Inc., ON,
Canada).

2.3 Formation of Intestinal ECM and Composite AlginateECM Hydrogels
Figure 2.1 presents a schematic overview showing the process from tissue harvest to
obtaining the pepsin-digested intestinal ECM that was used to generate hydrogels
comprised exclusively of ECM (Aim 2) or incorporated within alginate to produce the
composite alginate + ECM hydrogels (Aim 3).
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Figure 2.1 Process overview to generate the decellularized small intestinal ECMderived hydrogels. A) Small intestine was isolated from multiple mice (N=35-40 mice)
and pooled. The isolated intestines were B) decellularized using a novel protocol and then
C) the decellularized small intestine ECM was freeze-dried and cryo-milled to generate a
fine powder. D) The cryo-milled ECM was then digested with pepsin to generate an
ECM solution that was used to fabricate the intestinal ECM-derived hydrogels. E) ECMonly derived hydrogel droplets, which were crosslinked through pH neutralization and
incubation at 37 °C (50 μL in a 24-well plate). F) Composite hydrogels fabricated by
combining the pepsin-digested ECM with alginate, which was crosslinked through
incubation in a calcium chloride solution (50 μL droplet in 24-well plate).

2.3.1

Pepsin Digestion of Cryomilled Intestine

Lyophilized DSI samples were cryo-milled into a fine powder by placing each sample
into a Retsch 25 mL grinding jar with two 10 mm stainless steel milling balls. The
chambers were submerged in liquid nitrogen for 3 minutes prior to milling for 3 minutes
at 30 Hz (Retsch Mixer Mill MM 400 milling system). This cycle was repeated for a total
of three times. Cryomilled decellularized intestine were added at a concentration of
25 mg/mL to sterile 1 mg/mL porcine pepsin (3200-4500 mU/mg protein) (Sigma
CAT#P6887) in 0.05 M hydrochloric acid (total volume 5 mL) and digested for 24 hours
at room temperature under agitation at 100 rpm. Following digestion, while on ice, 1:10
volume of 10X PBS was added and the solutions were neutralized with 1 M sodium
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hydroxide in 20 μL increments. The resultant solutions were stored at 4 °C and kept on
ice during use.

2.3.2

Formation of Hydrogels Comprised Exclusively of ECM or
Matrigel

To generate the hydrogels comprised exclusively of intestinal ECM that were studied in
Aim 2, the 25 mg/mL pepsin-digested DSI solution was combined in a 1:1 ratio with
sterile filtered H2O to obtain a final ECM concentration of 12.5 mg/mL. The diluted
samples were pipetted in 50 μL droplets into a 24-well plate and crosslinked through
incubation at 37 °C for 1 hour, to allow self-assembly of the collagen within the samples.
Matrigel hydrogels were similarly fabricated as a control, following the manufacturer’s
protocols.

2.3.3

Formation of Composite Alginate-Based Hydrogels

Composite alginate + DSI hydrogels were investigated in Aim 3 by combining the
pepsin-digested DSI with alginate, which can be reversibly crosslinked through
incubation in solutions containing divalent cations, such as calcium. Control hydrogels
were fabricated from alginate alone, along with alginate combined with pepsin-digested
decellularized meniscus (DM) (prepared and donated by Sheradan Doherty, Flynn lab),
which was previously shown to induce the spreading of human adipose-derived stromal
cells encapsulated within alginate gels. Alginate was prepared by dissolving alginic acid
sodium salt, low viscosity (Alfa Aesar, B25266) in sterile filtered H2O to obtain a 2%
alginate concentration (w/v). The alginate solution was decontaminated for cell culture by
heating it to 98 °C for 30 minutes and cooled at room temperature before use. Composite
alginate-ECM gels were fabricated by combining 2% (w/v) alginate with pepsin-digested
intestine, meniscus, or with sterile filtered H2O in a 1:1 ratio. The samples were pipetted
in 50 μL droplets into a 24-well plate and immersed in 2% (v/w) calcium chloride for 1
hour at 37 °C to crosslink the alginate, and then washed with PBS to remove excess
calcium chloride.
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2.4 In vitro Assessment of NIH 3T3 Cells Encapsulated in
Hydrogels
2.4.1

NIH 3T3 Cell Culture and Encapsulation

A simplified cell culture model was used to validate that the pepsin-digested DSI
generated with the novel decellularization protocol would have bioactive effects on cell
populations encapsulated within the hydrogels, prior to moving on to the more complex
and heterogeneous cell populations within the organoid cultures. For the studies in Aim
2, the viability, spreading and metabolic activity of NIH 3T3 cells encapsulated were
assessed in the ECM-derived hydrogels comprised exclusively of pepsin-digested DSI in
comparison to Matrigel controls. Similar studies were performed in Aim 3, to compare
the response of NIH 3T3 cells encapsulated in the alginate + DSI hydrogels, to alginate
alone and alginate + DM hydrogel controls.
NIH 3T3 fibroblasts were cultured in proliferation medium comprised of DMEM (Wisent
bioproducts, CAT# 319-005-CL) supplemented with 10% fetal bovine serum (Gibco®,
Invitrogen, ON, Canada) and 1% penicillin/streptomycin (Gibco®, Invitrogen, ON,
Canada) in a 5% CO2 humidified incubator at 37 °C. To prepare the cells for the
encapsulation studies, cryopreserved P3-P7 cells were thawed and plated on T-75 tissue
culture polystyrene (TCPS) flasks (Corning, NY, United States) at a density of 5000
cells/cm2 in DMEM and cultured at 37 °C (5% CO2). The media was changed every 2
days, and cells were passaged at approximately 80% confluence. For passaging, the NIH
3T3 cells were released using trypsin-EDTA (0.25% Trypsin/2.21 mM EDTA from
Wisent Inc., QC, Canada), centrifuged at 400 x g for 5 minutes, resuspended in media,
and split into new T-75 flasks at a density of 5000 cells/cm2.
For the cell encapsulation studies in Aim 2, the NIH 3T3 cells were combined with the
diluted pepsin-digested DSI or Matrigel at a concentration of 1.0 x 106 cells/mL and
mixed well through gentle pipetting. The encapsulated gels were gently pipetted as 50 μL
droplets onto 12-well cell culture inserts (Greiner Bio-one, Germany), and allowed to
incubate at 37 °C (5% CO2) for 1 hour before adding 3 mL of warm proliferation medium
(1 mL in insert, 2 mL in well). Media was carefully changed every 2-3 days.
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For the cell encapsulation studies in Aim 3, NIH 3T3 cells were combined with the
alginate-based hydrogels (alginate + DSI, alginate + DM, alginate alone) at a
concentration of 1.0 x 106 cells/mL and mixed well through gentle pipetting. The
encapsulated gels were gently pipetted as 50 μL droplets onto 12-well cell culture inserts,
which were subsequently immersed in 1 mL of 2% calcium chloride and incubated at
37 °C (5% CO2) for 1 hour. Subsequently, the calcium chloride solution was removed,
and the samples were rinsed with PBS, before adding 3 mL of warm proliferation
medium (1 mL in insert, 2 mL in well). Media was carefully changed every 2-3 days.

2.4.2

Confocal Analysis of Cell Viability and Cell Spreading using
the LIVE/DEAD® Assay

NIH 3T3 cell viability was assessed through confocal microscopy at 24 hours, 3 days,
and 7 days post-encapsulation using the LIVE/DEAD® Viability/Cytotoxicity Assay
(Invitrogen CAT#L3224). Live cells were identified through Calcein AM staining (green)
and dead cells were labeled using ethidium homodimer-1 (EthD-1) (red). At each
timepoint, triplicate gels (n=3 replicates/group at each timepoint, N=3 experimental
repeats) from each group were rinsed with PBS and incubated at 37 °C in 4 μM EthD-1
and 2 μM Calcein AM in PBS for 45 minutes. Following incubation, non-overlapping
images were taken using a 5X objective across the entire cross-section of each gel at
defined depths ranging from 70 μm to 170 μm using the Zeiss LSM800 Confocal
Microscope.

2.4.3

Metabolic Activity Analysis

The metabolic activity of the encapsulated 3T3 cells was assessed at 24 hours, 3 days,
and 7 days post-encapsulation using the CyQUANT™ MTT Cell Viability Assay kit
(Thermo Fisher Scientific Inc. CAT#V13154) (n=3 replicates/group, N=5 experimental
repeats for Day 1 to Day 7 studies, N=3 for Day 7 only studies), following previously
published methods116. In brief, the samples were incubated in 3 mL (1 mL in insert, 2 mL
in well) of MTT solution (0.5 mg/mL in cell culture medium) at 37 °C for 4 h. Next, each
sample was crushed within a microcentrifuge tube using a plastic pestle, and
subsequently incubated in 800 μL of DMSO for 1 h at 37 °C under agitation (100 rpm) to
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extract the formazan crystals. Samples were then centrifuged at 15,000 x g for 15 minutes
to remove the gels and only the supernatant was used for measurements. The absorbance
was measured at 540 nm and corrected for background absorbance at 690 nm using a
CLARIOstar® Multimode Microplate Reader (BMG Labtech, ON). In addition, the
absorbance values from unseeded hydrogel controls were subtracted from the values for
the hydrogels containing the encapsulated 3T3 cells to account for potential background
associated with the presence of scaffolding materials.

2.5 Intestinal Organoid Culture
2.5.1

Isolation of Intestinal Crypts

After confirming that the pepsin-digested DSI had bioactive effects on NIH 3T3 cells, the
next studies focused on encapsulating primary intestinal organoids within the hydrogels
to evaluate the ability of pepsin-digested DSI to support intestinal organoid growth and
viability. For the studies in Aim 2, the growth of intestinal organoids over 14 days was
assessed in the ECM-derived hydrogels comprised exclusively of pepsin-digested DSI in
comparison to Matrigel controls. Similar studies were performed in Aim 3, to compare
the response of intestinal organoids encapsulated in the alginate + DSI hydrogels to
alginate alone.
Adult male and female C57BL/6 mice (2–4 months in age) were euthanized by CO2
overdose and their small intestines were surgically extracted. The methods for organoid
culture were adapted from methods previously described by Sato et al36. Briefly, the
small intestines were perfused with PBS using a needle and syringe to remove intestinal
contents. Next, the intestines were cut open longitudinally and scraped using a glass
cover slip to remove the villi. The intestines were then cut into 0.5 mm pieces and
transferred into a 50 mL centrifuge tube and washed vigorously with PBS 3-5 times.
Following PBS washing, the intestinal tissue was resuspended in 10 mL of 2.5 mM
EDTA in PBS and incubated at 4 °C in a rotator for 45 minutes. The PBS solution was
then removed, and the intestine was resuspended in 10 mL of fresh PBS. Once
resuspended, the solution was pipetted 10-15 times to release the crypts from the tissue
fragments. The solution was then passed through a 70 μM cell strainer and centrifuged at
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88 x g for 5 minutes. The pellet was resuspended in 5 mL DMEM (Fisher) containing 1X
Glutamax (Life Tech), 1X (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (Hepes;
LifeTech), and 1X antibiotic/mycotic penicillin and streptomycin solution (Life Tech).
The samples were then centrifuged at 50 x g for 5 minutes and the supernatant was
removed. The pellet of crypts was counted, and the crypts were then resuspended in the
appropriate volume of Matrigel (Fisher CAT#356231) to obtain ~2000 intestinal
crypts/mL. Twenty-four well plates were pre-warmed in the incubator prior to adding 50
μL droplets of Matrigel per well. Plates were warmed in the incubator for 10 minutes
prior to adding 500 μL of DMEM. Each well was supplemented with 50 ng/mL
epidermal growth factor (EGF), 1 μg/mL R-spondin, and 100 ng/mL mNoggin. Media
was changed every 4 days, and with fresh supplements added every other day.

2.5.2

Organoid Passaging and Encapsulation

Intestinal organoids were first cultured and maintained in Matrigel before passaging
into the hydrogels fabricated in Aim 2 and Aim 3. Intestinal organoids were passaged
every 8-12 days. Briefly, media was removed from each well and replaced with 1 mL of
cold DMEM to disrupt the Matrigel. The organoids were pipetted up and down using a
1000 μL pipette tip to release them from the Matrigel and transferred into a 15 mL
tube. The organoids were then broken into smaller fragments by pipetting up and down
with a glass Pasteur pipet 5-10 times and then centrifuged for 5 minutes at 50 x g before
being resuspended and re-seeded in either the pepsin-digested DSI hydrogels or
Matrigel (Aim 2), or the alginate-based hydrogels (alginate + DSI, alginate + DM,
alginate alone) (Aim 3), following the methods described above. Furthermore, to assess
the viability of intestinal stem cells in the DSI hydrogels (Aim 2), the organoids grown
for 14 days in DSI hydrogels were passaged back into fresh DSI or Matrigel.

2.5.3

Organoid Imaging and Area Analysis

Organoids in both Aim 2 and Aim 3 were imaged at days 1, 7, and 14 which were an
early, intermediate, and late timepoint, respectively, using 4x-20x objectives on the
EVOS FL Auto. Two-dimensional image analysis was performed to measure the change
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in organoid area from day 1 to day 7 post-encapsulation in either the pepsin-digested DSI
hydrogels and Matrigel (Aim 2), or in the alginate-based hydrogels (alginate + DSI and
alginate alone) (Aim 3). Non-overlapping images were taken at a constant depth of each
gel using a 4X objective. The same gels and regions were imaged on both days 1 and day
7. Organoid area was measured using the ImageJ software. For organoid area
quantification, the area of n > 100 organoids per group was quantified/timepoint using
positive pixel counting, and used to estimate the average fold-change in size from days 1
to 7 as a measure of organoid growth.

2.5.4

Histological Analysis

Intestinal organoids cultured for 10 days in either Matrigel or DSI hydrogels (Aim 2)
were fixed overnight at 4 °C in 4% paraformaldehyde. Next, the paraformaldehyde was
removed, and the samples were carefully rinsed with PBS. Two hundred μL of prewarmed 2% (v/w) agarose was carefully added to the wells and allowed to solidify at
room temperature. The agarose gels containing the encapsulated organoids were then
carefully embedded in Tissue-Tek OCT compound and immediately placed on dry ice in
preparation for cryosectioning (7 μm sections) with a Leica CM3050 S cryostat. Samples
were warmed at room temperature for 15 minutes and then rinsed in H2O. Sections were
stained with hematoxylin and eosin to visualize the cells within the surrounding ECM
following standard protocols. Eosin (eosinophilic) which is an acidic dye is negatively
charged and stains basic structures like cytoplasm and extracellular proteins red or pink.
Hematoxylin (basophilic), on the other hand, is a basic dye that stains acidic structures
such as the nuclei in a purplish blue color. Images were obtained using the EVOS FL
Auto.

2.6 Statistical Analyses
All statistical analysis were performed using GraphPad Prism 7.0. Statistical analyses
were carried out by t-test and two-way ANOVA as detailed in the figure captions. Three
normality tests were carried out for all studies, however due to low statistical power (low
N value), tests either passed for normality or did not have a large enough sample size. All
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numerical data are expressed as mean ± standard deviation (S.D.). Differences with
p < 0.05 were considered statistically significant.
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Chapter 3

3

Results

3.1 Characterization of Decellularized Intestinal Tissues
The first aim of this project was to establish a novel mouse intestinal decellularization
protocol that removes cellular content while preserving the extracellular matrix (ECM)
composition. The small intestine from 35-40 adult mice was processed together as a
single batch of decellularized tissue. Briefly, the novel decellularization protocol
developed involved dissecting the small intestine from adult mice, followed by mincing
and processing the tissue using a 4-day process that included freeze-thaw cycles in
hypotonic solutions, Triton X-100 detergent extractions, and enzymatic digestion using
deoxyribonuclease (DNase) and ribonuclease (RNase).
Decellularized samples were compared to native tissue controls using histological and
biochemical analyses. To assess the removal of cellular components, hematoxylin and
eosin (H&E) staining was performed, which stains cellular components in purple and
ECM components in pink (Figure 3.1). Representative H&E staining of the native and
decellularized small intestine (DSI) showed that the protocol effectively removed cellular
components (absence of purple stained nuclei on the right panel of Figure 3.1), while
retaining ECM components, with only the pink staining characteristic of collagen
visualized in the DSI samples.
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Figure 3.1. H&E staining confirms effective removal of cellular content following
decellularization. Representative H&E staining of native and DSI showing effective
removal of cellular components (including absence of basophilic cell nuclei that normally
stain purple) while retaining ECM components (stained pink due to its eosinophilic
nature and staining is characteristic of collagen) following decellularization. Black
arrows indicate specific intestinal regions including muscularis mucosa, intestinal crypts,
and lamina propria (n=3 cross-sections/decellularization batch, N=3 independent
decellularization batches). Scale bar=100 μm.
To confirm the effectiveness of cell extraction, 4’,6-diamidino-2-phenylindole (DAPI)
fluorescence staining was performed to visualize cell nuclei within the DSI samples
relative to native tissue controls (Figure 3.2A). Notably, no visible nuclei remained in the
tissues at the end of processing. To further validate these findings, the PicoGreen assay
was used to quantify the double-stranded DNA (dsDNA) content in the native and DSI
samples (Figure 3.2B). A significant reduction in the dsDNA content was observed
following decellularization, with an average decrease of 91.56 ± 9.73% relative to native
tissue controls.
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Figure 3.2. DAPI staining and PicoGreen quantification verify that the new
decellularization protocol effectively extracted cellular contents from the mouse
small intestines. A) Representative DAPI nuclear staining (shown in grayscale) of native
(left panel) versus DSI (right panel) mouse small intestine, with no visible nuclei detected
following decellularization (n=3 cross-sections/decellularization batch N=3 independent
decellularization batches). Scale bar=100 μm. B) Quantitative analysis of doublestranded DNA (dsDNA) content using the PicoGreen assay confirmed that
decellularization was effective at extracting cells from the tissues. Values are reported
based on dry weight. (N=7 independent decellularization batches). Mean ± S.D, Paired ttest; **p<0.01.
Following decellularization, the collagen content of the intestinal tissue samples was
assessed. The samples were stained using picrosirius red and imaged using polarized light
microscopy to visualize the network of collagen fibers. The imaging revealed a
qualitatively denser network of collagen fibers stained red in the DSI tissues relative to
the native tissue controls (Figure 3.3A). In addition, a hydroxyproline assay was used to
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quantify the collagen content in the native tissue and DSI samples (Figure 3.3B),
revealing a significant increase in the relative collagen content following
decellularization, consistent with the removal of cells and potentially other ECM
constituents.

Figure 3.3. Picrosirius red staining and the hydroxyproline assay indicate an
increase in the relative collagen content following decellularization. A)
Representative images of picrosirius red staining showing that the DSI contained a
qualitatively more dense network of collagen fibers than the native tissue samples. (n=3
cross-sections/decellularization batch, N=3 independent decellularization batches). Scale
bar=500 μm. B) Quantification of total collagen content by the hydroxyproline assay
showed higher relative levels in the DSI samples relative to the native tissue controls.
Values are reported based on dry weight. (N=7 independent decellularization batches).
Mean ± S.D, Paired t-test; ***p<0.001.
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Glycosaminoglycan (GAG) content was assessed by toluidine blue staining and the
dimethylmethylene blue assay (Figure 3.4). Toluidine blue staining revealed qualitatively
similar levels of GAG staining (purple) in the DSI samples compared to the native tissues
(Figure 3.4A). Moreover, the DMMB assay confirmed there were similar levels of
sulphated GAGs (sGAG) in both the DSI and native small intestine samples, with no
significant difference observed between the groups.

Figure 3.4. Sulphated glycosaminoglycan (sGAG) content was retained following
decellularization. A) Representative toluidine blue staining showing staining of GAGs
(purple) and nucleic acids (blue) in the native versus DSI. (n=3 crosssections/decellularization batch, N=3 independent decellularization batches). Scale
bar=100 μm. B) Quantitative analysis of sGAG content with the DMMB assay showed
similar levels in the native and DSI samples. Values are reported based on dry weight.
(N=7 independent decellularization batches). Mean ± S.D, Paired t-test.
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Immunohistochemical staining was additionally used to confirm the presence of key
ECM components in the DSI samples, and compare their distribution relative to the
native tissue controls (Figure 3.5). Immunofluorescence staining confirmed the retention
of collagen I, collagen IV, fibronectin, and laminin following decellularization, which
were all well distributed throughout both the DSI and native tissue samples.
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Figure 3.5. Immunofluorescence staining confirmed the retention of ECM
components following decellularization. Representative staining for collagen I,
collagen IV, fibronectin, and laminin following decellularization demonstrated retention
of all markers of interest. All samples were counterstained with DAPI (blue) for cell
nuclei. (n=3 cross-sections/decellularization batch, N=3 independent decellularization
batches). Scale bar=200 μm. Abbreviations: COL I=collagen type I, COL IV=collagen
type IV.
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3.2 In Vitro Assessment of NIH 3T3 Cells Encapsulated and
Cultured in Intestinal ECM Hydrogels and Matrigel
DSI generated in Aim 1 was lyophilized, cryo-milled, and enzymatically digested with
pepsin. The pepsin-digested ECM, with a final ECM concentration of 12.5 mg/mL, was
incubated at 37 °C for 1 hour to create the hydrogels. To confirm the bioactivity of the
ECM generated with the novel decellularization protocols, a LIVE/DEAD assay was used
with confocal imaging to assess cell viability and spreading of NIH 3T3 murine
fibroblasts encapsulated within the DSI hydrogels, relative to Matrigel controls at days
1, 3, and 7 post-encapsulation (Figure 3.6A). Both groups showed qualitatively similar
viability and cell spreading, an indication of cell attachment to ECM components, over
the 7-day culture period, with the staining patterns indicating that the cells were
proliferating over time.
To verify these results, the MTT assay was performed to quantitatively compare the
metabolic activity of the encapsulated 3T3 cells within the DSI hydrogels and Matrigel
controls (Figure 3.6B). There were no significant differences in the metabolic activity
between the groups at any of the time points examined. Further, there was a significant
increase in metabolic activity on day 7 as compared to days 1 and 3 for both groups,
consistent with an increase in cell number.
To additionally assess batch-to-batch variability in the decellularization process (i.e.
ECM derived from tissues processed separately), the metabolic activity of the
encapsulated NIH 3T3 cells was assessed on day 7 in DSI hydrogels prepared from three
independent decellularization batches relative to Matrigel controls (Figure 3.6C).
Importantly, minimal variation was observed between the 3 ECM batches, supporting
that the protocol was robust and repeatable for generating bioactive ECM that could
support the viability and growth of encapsulated cell populations.
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Figure 3.6. Assessment of cell viability and metabolic activity of NIH 3T3 murine
fibroblasts encapsulated within DSI hydrogels or Matrigel controls showed that
both platforms similarly supported cell viability and growth. A) Representative
confocal microscopy images showing stained calcein+ live (green) and EthD-1+ dead
(red) 3T3 fibroblasts within DSI hydrogels or Matrigel controls. High cell viability was
maintained with both platforms over the 7-day culture period. Cell spreading was
observed at all time points in both groups. Insets on Day 3 show the presence of
infrequent red (dead) cells. (n=3 hydrogels per timepoint/trial, N=3 trials with
independent ECM batches). Scale bar=500 μm. B) Quantification of metabolic activity
using a MTT assay showed similar metabolic activity in 3T3 cells encapsulated within
the DSI hydrogels or Matrigel across all time points. Higher metabolic activity levels
were observed at day 7 as compared to day 1 and 3 for both groups, consistent with cell
proliferation. (N=5 separate 3T3 encapsulations). Mean ± S.D, Two-way ANOVA;
*p<0.05, ***p<0.001, ****p<0.0001. C) Metabolic activity of 3T3 cells encapsulated in
DSI hydrogels prepared from different ECM batches, showing consistency in the
response to the developed bioscaffolds and comparable metabolic activity levels to
Matrigel controls at 7 days post-encapsulation. (N=3 independent decellularized and
pepsin-digested DSI batches). Mean ± S.D, Unpaired t-test. Metabolic activity was
measured by absorbance values in arbitrary units (a.u.) (B-C).
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3.3 In Vitro Assessment of Mouse Intestinal Cells
Encapsulated and Cultured in Intestinal ECM Hydrogels
and Matrigel
To assess the ability of DSI hydrogels to promote intestinal organoid growth, primary
mouse intestinal organoids were first cultured in Matrigel prior to being passaged and
encapsulated within both Matrigel and DSI hydrogels (Figure 3.7). Intestinal organoids
were cultured for 14 days and imaged on days 1, 7, and 14 post-encapsulation (Figure
3.7A). Organoid growth over 14 days appeared qualitatively similar in the DSI hydrogels
as compared to Matrigel. Images taken at higher power on day 7 post-encapsulation
revealed budding in the organoids and granule-containing cells in the budding crypts of
both Matrigel- and DSI-grown organoids (Figure 3.7B). Organoid area was calculated
using Image J on day 1 and 7 post-encapsulation. The fold change in organoid area on
day 7 relative to day 1 was similar in the DSI hydrogels and Matrigel controls (Figure
3.7C). Representative H&E staining of different organoids grown in Matrigel or DSI at
10 days post-encapsulation show an epithelial layer (purple stained nuclei) with budding
crypts surrounding a hollow lumen (Figure 3.7D).
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Figure 3.7. DSI hydrogels promote the growth of mouse intestinal organoids in vitro.
A) Time course of mouse intestinal organoid growth is shown. Comparable organoid
growth was seen over a 14-day culture period in the DSI hydrogels as compared to
Matrigel controls. Insets show high power images of a single organoid over the culture
period. (N=3 independent ECM batches). Scale bar=1 mm. B) Representative brightfield
microscopy images of organoids grown in Matrigel versus DSI hydrogels at day 7.
Images of organoids encapsulated within both Matrigel and DSI hydrogels revealed
granule-containing cells in the budding crypts, consistent with the presence of Paneth
cells (black arrows). Scale bar=200 μm. C) Quantification of size of organoids grown in
Matrigel versus DSI hydrogels from day 1 to 7, showing similar organoid growth in
both groups. (n ≈ 175 organoids per group were quantified/timepoint, N=3 independent
organoid cultures). Mean ± S.D, Unpaired t-test. D) Representative H&E staining of
different organoids grown in Matrigel versus DSI hydrogels at day 10 postencapsulation. Images revealed an epithelial monolayer (black arrows) surrounding a
lumen in both hydrogels. (n=3 cross-sections, N=3 independent organoid cultures). Scale
bar 50=μm.
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Next, mouse intestinal organoids grown in DSI hydrogels were passaged into either
Matrigel or DSI hydrogels and imaged on days 1, 7, and 14 to assess growth as an
indicator of viability (Figure 3.8A). The organoids encapsulated within the DSI hydrogels
and Matrigel both showed growth over the 14 day culture period. However, there were
fewer organoids that increased in size in the DSI hydrogels as compared to Matrigel
(Figure 3.8B).

Figure 3.8. Organoids remain viable following passaging from the DSI hydrogels. A)
Schematic of the timeline for organoid culture followed in panel B. B) Representative
brightfield microscopy images of mouse intestinal organoids cultured in DSI hydrogels
and then passaged into new DSI hydrogels or Matrigel. Images were taken at days 1, 7,
and 14 post-passaging. Intestinal organoids passaged into either DSI hydrogels or
Matrigel were followed over 14 days, with fewer growing organoids in the DSI
hydrogel group versus the Matrigel controls. (N=3 independent ECM batches). Scale
bar=1 mm.
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3.4 In Vitro Assessment of NIH 3T3 Cells Encapsulated and
Cultured in Alginate-based Hydrogels
DSI generated in Aim 1 was incorporated within alginate to form a composite hydrogel
platform, which may have more tunable mechanical properties and allow for reversible
cell encapsulation. Three groups were investigated: 1% alginate, 1% alginate + DSI, and
1% alginate + Decellularized Meniscus (DM), as a positive control for cell spreading.
The alginate-based hydrogels were crosslinked using calcium chloride for 1 hour at
37 °C.
Similar to the previous studies with the hydrogels comprised exclusively of DSI, initial
testing focused on confirming that the ECM had bioactive effects within the composites
using encapsulated 3T3 murine fibroblasts. The LIVE/DEAD assay with confocal
imaging confirmed that all groups showed high viability across the 7-day culture period
(Figure 3.9A). Cell spreading was observed in the alginate + DSI and alginate + DM
groups, whereas the alginate alone group had a spherical cell morphology, supporting that
the incorporated ECM provided cell-adhesive cues. The MTT assay showed that the
metabolic activity was higher in the fibroblasts encapsulated within the alginate + DSI
hydrogels compared to the cells encapsulated in alginate alone, and similar to alginate +
DM control group at days 1, 3, and 7 post encapsulation (Figure 3.9B). The metabolic
activity of cells encapsulated within the alginate + DSI hydrogels was higher at day 7
relative to day 1 and day 3, consistent with cell growth in the composites but not the
alginate alone controls. Assessment of batch-to-batch variability using the MTT assay at
day 7 post-encapsulation, showed consistent results in the composite hydrogels generated
with 3 different DSI batches (Figure 3.9C).
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Figure 3.9. Incorporation of pepsin-digested DSI within alginate hydrogels
promoted cell spreading and growth of encapsulated NIH 3T3 murine fibroblasts.
A) Representative confocal images showing calcein+ live (green) and EthD-1+ dead (red)
3T3 fibroblasts in all hydrogels, supporting that high cell viability was maintained
throughout the culture period. Cell spreading was observed at all time points in the
alginate + DSI and alginate + DM hydrogels, but not in the alginate alone control group.
(n=3 hydrogels per timepoint/trial, N=3 trials with independent ECM batches). Scale
bar=500 μm. B) Quantification of metabolic activity through the MTT assay showed
higher metabolic activity levels in the alginate + DSI group relative to the alginate alone
at all time points, supporting that the incorporated ECM had bioactive effects on the
encapsulated cells. Metabolic activity levels of the cells encapsulated within the alginate
+ DSI hydrogels was higher at 7 days as compared to both day 1 and day 3, consistent
with cell proliferation when the ECM was incorporated. (N=5 separate 3T3
encapsulations). Mean ± S.D, Two-way ANOVA; *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001. C) Quantification of metabolic activity through the MTT assay showed
consistently higher levels of metabolic activity at 7 d in the alginate + DSI samples
relative to the alginate alone across three separate ECM batches. (N=3 independent
decellularized and pepsin digested ECM batches). Mean ± S.D, Unpaired t-test.
Metabolic activity was measured by absorbance values in arbitrary units (a.u.) (B-C).
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3.5 In Vitro Assessment of Intestinal Organoids
Encapsulated within Alginate-based Hydrogels
To assess the ability of alginate-based hydrogels to support the growth of intestinal
organoids, primary mouse intestinal organoids were cultured in Matrigel prior to being
passaged and encapsulated within alginate alone or composite alginate + DSI hydrogels
(Figure 3.10). Intestinal organoids were imaged using brightfield microscopy on days 1,
7, and 14 post-encapsulation (Figure 3.10A). Organoids seemed visibly similar in the
alginate + DSI hydrogels versus the alginate alone hydrogels. More specifically, there
was no noticeable change in the size or structure of the organoids in the alginate + DSI
hydrogels on day 14 as compared to days 1 and 3. To verify the lack of apparent organoid
growth, the organoid area was calculated on day 1 and 7 post-encapsulation using ImageJ
(Figure 3.10B). The fold change in organoid area was similar in the alginate + DSI
hydrogels as compared to the alginate alone group, with neither group showing a
significant increase in size over time.
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Figure 3.10. The incorporation of DSI within the alginate hydrogels was insufficient
to promote the growth of mouse intestinal organoids in vitro. A) Time course of
mouse intestinal organoids showed a lack of organoid growth over 14 days in both the
alginate + DSI group and alginate alone group. (N=3 independent ECM batches). Scale
bar=1 mm. B) Analysis of the change in size of organoids cultured in alginate versus
alginate + DSI from days 1 to 7 post-encapsulation. The analysis showed no organoid
growth in both hydrogels. (n ≈ 100 organoids per group/timepoint, N=3 independent
organoid cultures). Mean ± S.D, Unpaired t-test.
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Chapter 4

4

Discussion

The primary objective of this thesis was to develop a tissue-specific extracellular matrix
(ECM)-derived bioscaffold that could replace Matrigel in intestinal stem cell (ISC)based organoid cultures. Matrigel is an ECM product produced by mouse sarcoma cells
that is enriched in basement membrane components. While it provides a highly
supportive microenvironment for organoid growth36,48–50 the fact that Matrigel is
derived from a cancer cell line limits its clinical applicability51,52. As an alternative,
bioscaffolds derived from decellularized tissues can mimic the native ECM and provide
tissue-specific biological cues that can regulate proliferation and differentiation64. In this
study, a novel decellularization protocol was developed for isolating the small intestinal
ECM from mouse tissues and methods were established to generate hydrogels
incorporating the decellularized small intestine (DSI) that could be used to encapsulate
and culture intestinal cells.
In contrast to many protocols in the literature56,67,74,81,85,88,89, the decellularization protocol
developed avoids the use of stronger ionic detergents, which can cause greater loss of
more soluble ECM components including growth factors and glycosaminoglycans
(GAGs)67,117, and can be more difficult to remove following decellularization, raising
cytotoxicity concerns74,118,119. The decellularization protocol included freeze-thaw cycles
in a hypotonic solution to promote cell lysis followed by 1% Triton X-100 detergent
extraction and digestion with DNase and RNase to extract cellular components, and
finally, extensive washing to remove residual detergent and cellular debris. This protocol
was highly effective at extracting nucleic acids from the tissues as determined by DAPI
staining and quantification of double-stranded DNA (dsDNA) content, supporting that
the tissues were effectively decellularized. More specifically, the protocol resulted in a
~92% reduction in the dsDNA content, which is similar to other protocols in the literature
that used the ionic detergent SDS (~95% reduction) or the non-ionic detergent Triton X100 (~94% reduction) to decellularize mouse small intestine81.
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Collagen is the primary structural protein in the small intestine and it is known to play an
important role in regulating the function of intestinal epithelial cells7,11,15. Thus, it is
critical that a decellularization protocol is able to retain collagen7. Analysis of collagen
content via picrosirius red staining and the hydroxyproline assay indicated that there was
a relative enrichment in collagen content at the end of processing. These findings are
consistent with previous reports in the literature and are consistent with the loss of cells
and other ECM components during processing56,85.
We additionally measured the retention of GAGs in our decellularized tissue, as GAGs
can sequester growth factors and play a key role in maintaining tissue hydration as a
result of their hydrophilic nature7,120. In addition, cells can also interact directly with
GAGs through cell surface receptors, which can modulate cellular processes including
intestinal crypt homeostasis7,32,35. Thus, augmenting GAG retention may enhance the
bioactivity of decellularized tissues. Based on toluidine blue staining and the
dimethylmethylene blue (DMMB) assay, the novel protocol developed in this thesis was
favorable for GAG retention, with no significant difference between the decellularized
and native tissue samples observed. In contrast, previous studies have shown a significant
loss in GAG content following increased sodium deoxycholate cycles in rat small
intestine, and another study reported only ~42% GAG retention following sodium
dodecyl sulphate treatment in porcine small intestine, potentially linked to the use of
stronger ionic detergents85,89.
Immunohistochemical staining confirmed the presence of collagen types I and IV,
fibronectin, and laminin within the decellularized tissue samples at the end of processing.
Collagen I and IV are known to be distributed throughout the ECM in the small
intestine7. Collagen I defines the tissue structure, while collagen IV is integral to the
basement membrane, where it is in direct contact with epithelial and mesenchymal cells
and is important for the regulation of epithelial cell homeostasis7,15 Fibronectin is an
important mediator of cell-matrix interactions and can regulate cell functions including
cell proliferation, adhesion, and differentiation7,24–26. Similarly, laminin is another
abundant glycoprotein found in the intestinal crypt membrane, which can regulate the
function of the intestinal epithelium, including promoting cell adhesion and directing
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differentiation21,22. Interestingly, Gjorevski et al previously showed that the addition of
laminin and fibronectin to polyethylene glycol (PEG) hydrogels in vitro enhanced mouse
ISC proliferation and survival, supporting that the retention of these components within
our DSI may be favorable for organoid growth102.
For intestinal organoid culture, there is specific interest in the development of hydrogel
platforms that can encapsulate cells with high viability within a 3D microenvironment
that mimics the native small ISC niche57. To generate such platforms, decellularized
tissue can be enzymatically digested to obtain polypeptide solutions that can
subsequently be induced to form hydrogels by promoting the self-assembly of the
remaining collagen fibrils56,57,99. In this study, a protocol was established to make
hydrogels from pepsin-digested intestinal ECM prepared with the decellularized mouse
tissues. A wide range of pepsin-digestion protocols have been reported in the literature
for tissue sources including adipose tissue, bone, cartilage, colon, small intestine, and
heart tissue56,57,94–98. Notably, pepsin digestion requires careful optimization as the
peptide solution generated can be affected by multiple factors including digestion time,
pH, enzyme concentration, substrate concentration, temperature, and agitation57, which
can impact hydrogel formation. The finalized protocol developed in this thesis involved
24 hours of digestion at room temperature, with 1 mg/mL pepsin and an ECM
concentration of 25 mg/mL. Increasing the temperature to 37ºC during digestion, or
decreasing the ECM concentration to 10 mg/mL resulted in unstable hydrogel formation,
likely due to over-digestion of the ECM. Similarly, increasing the ECM concentration to
50 mg/mL resulted in ineffective digestion. Interestingly, others have reported fabricating
stable intestinal-derived hydrogels with ECM concentrations as low as 6 mg/mL using
decellularized porcine tissues56,57. This difference in hydrogel stability could be attributed
to species-specific differences in the ECM composition and could also be influenced by
the specific decellularization protocols used.
As a first step in testing the new intestinal ECM-derived hydrogel platform, a simple cell
culture model involving the murine 3T3 fibroblast cell line was used to verify that the
pepsin-digested intestinal ECM supported cell viability and had bioactive effects on
encapsulated cell populations. Positively, LIVE/DEAD staining indicated that the DSI
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provided cell adhesive cues that supported cell spreading over time121, and the MTT
results indicated that there was cell expansion over time, similar to Matrigel. Our
findings are consistent with a previous study that showed high viability and cell
spreading in 3T3 cells encapsulated and cultured in type I collagen hydrogels over 6
days122. Similarly, another study reported high viability, cell growth, and cell spreading
of 3T3 cells following encapsulation and 7 days of culture within ECM-derived
hydrogels comprised of pepsin-digested decellularized porcine dermis or decellularized
urinary bladder123. Overall, these findings support the cell-supportive nature of ECMderived hydrogels fabricated from pepsin-digested ECM.
When intestinal organoids were encapsulated within the DSI hydrogels and cultured for
14 days, similar growth patterns were observed as compared to the Matrigel controls,
with budding structures including granule-containing cells, consistent with Paneth cells36,
observed starting at 7 days. Additionally, H&E staining of organoids grown in DSI
versus Matrigel revealed similar structures with an epithelial cell monolayer with
budding crypts surrounding a central lumen. These findings are consistent with the work
of Clevers and colleagues, who developed ECM-derived hydrogels comprised of pepsindigested decellularized porcine small intestine and showed that they could support the
growth of human and mouse-derived small intestinal organoids56. More specifically, their
quantitative analyses of size based on brightfield imaging also revealed that the mouse
and human intestinal organoids showed similar growth in their hydrogels to those
cultured in Matrigel. Further, their study revealed that intestinal organoids could be
maintained over several passages, but they noted a decrease in the quality of the
morphology of their human organoids over multiple passages, based on brightfield
imaging. Similarly, in our current study, intestinal organoids passaged from DSI back
into fresh DSI or Matrigel revealed that the organoids passaged into the DSI hydrogels
grew noticeably slower compared to those passaged into Matrigel. Additional studies
focused on compositional analyses of Matrigel and DSI are needed to determine if there
are growth factors present in Matrigel which are absent in the DSI. Additionally,
mechanical properties such as gel stiffness may be playing a role in the regulation of the
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ISCs and can be evaluated by performing compression testing using a CellScale
MicroTester system to measure the Young’s Modulus of the gels.
While the DSI hydrogels showed favorable cell supportive qualities including the ability
to support the growth of established organoids, there were some technical disadvantages
noted with their use, including that they were less transparent than Matrigel, which
made imaging more challenging. Furthermore, unlike Matrigel, the DSI hydrogels were
not thermally reversible and required mechanical disruption to passage the intestinal
organoids. Therefore, additional studies focused on degrading the ECM before passaging
may aid in the successful passaging of DSI-grown organoids. In addition, the hydrogels
did not consistently adhere to the tissue culture plates, making it more difficult to track
specific organoids by microscopy over time. To try to address these limitations, the final
goal of this study was to investigate composite alginate + DSI hydrogels, with the goal of
creating a more structurally robust and tunable platform that integrated the bioactivity of
the intestinal-derived ECM124. Alginate was selected as the base material as it has
reversible gelation properties that are advantageous for cell extraction124. It is also well
known to support the viability of encapsulated cells in vitro59,60.
In the current study, the incorporation of pepsin-digested ECM sourced from the DSI or
decellularized porcine meniscus as a control was shown to promote the spreading and
growth of encapsulated 3T3 fibroblasts relative to alginate alone controls. These findings
are consistent with previous studies in the literature on the incorporation of ECM proteins
within alginate122. For example, Liu et al. observed that the incorporation of type I
collagen into alginate hydrogels promoted high viability on day 6 relative to day 0, and
cell spreading of 3T3 cells based on LIVE/DEAD staining at 6 days postencapsulation122. Overall, these findings indicate that the incorporation of ECM peptides
within alginate can provide biological cues needed to support cell attachment and
growth59.
However, when mouse intestinal organoids were encapsulated within the alginate-based
hydrogels, no cell growth was observed over the 14 day culture period. In a previous
study, alginate hydrogels were shown to support the growth of organoids derived from
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human induced pluripotent stem cells (iPSCs) when cultured with the addition of
mesenchymal supporting cells and growth factors including epidermal growth factor
(EGF), R-Spondin2, and Noggin-Fc59. However, the number of spheroids that gave rise
to organoids was lower in all alginate concentrations relative to Matrigel on day 28
post-encapsulation. Notably, organoids derived from iPSCs are distinct from organoids
grown from primary adult tissues, although they may provide a basis for optimizing
growth conditions for primary organoids. Importantly, the authors reported that varying
the alginate concentration (0.5%, 1%, 2%, 3%, and 4% alginate) affected organoid
viability and growth, with enhanced viability in the 1% and 2% alginate concentrations.
These findings suggest that it may be possible to tune our composite alginate platform to
better support intestinal organoid growth, and future studies could explore varying other
parameters such as the final ECM concentration within the gels or the addition of other
growth factors and/or co-culture with mesenchymal stromal cell46,125.

4.1 Conclusion and Significance
In summary, a new decellularization protocol was developed for mouse small intestine.
The decellularization protocol was confirmed to effectively remove cellular content while
preserving key ECM constituents present in the native small intestine including GAGs,
collagens, fibronectin, and laminin. A protocol was subsequently developed to fabricate
intestinal ECM-derived hydrogels from pepsin-digested DSI. Hydrogels comprised
exclusively of ECM showed bioactive effects on encapsulated 3T3 cells and
demonstrated their ability to promote primary mouse intestinal organoid growth similar
to Matrigel. Composite hydrogels were formed by incorporating pepsin-digested DSI
within alginate. The inclusion of the ECM within the composite gels was shown to have
bioactive effects on encapsulated 3T3 cells relative to alginate alone. While the alginatebased hydrogels were successfully used to encapsulate intestinal organoids, no detectable
organoid growth was noted over the 14 day culture period, suggesting that further
optimization of the platform was necessary for this application. Overall, this body of
work provides insight into how tissue-specific ECM can be used as a bioscaffold for
supporting and promoting ISC growth.
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4.2 Implications and Future Directions
This thesis developed two novel intestinal ECM-derived hydrogel platforms and serves as
a basis for strategies seeking to harness the intestinal-derived ECM for the culture of
mouse intestinal organoids. These hydrogels showed promise as a starting point for
replacing Matrigel as the matrix for culturing intestinal organoids, and may also prove
to be a useful tool for in vivo cell delivery in future applications. Future studies should
focus on further characterizing the organoids cultured within these novel hydrogel
platforms, including identifying the cell types present. This can be done by histologic
analyses and immunofluorescent labelling of specific cell types and comparison to
organoids grown in Matrigel.
Further investigation of the proteins and growth factors present in the decellularized
small intestine and the hydrogels fabricated from the pepsin-digested DSI relative to
Matrigel would also be recommended. Compositional analysis may help to identify
specific proteins involved in regulating ISC growth and organoid formation. One
approach would be to conduct in-depth proteomic analyses using high throughput mass
spectrometry techniques to identify proteins present and their relative abundance within
the ECM-derived materials56,126. Currently, Matrigel-based cultures require the addition
of growth factors including R-spondin, Noggin, and EGF to enable organoid formation
and growth36. Therefore, compositional analyses may allow us to identify growth factors
that may be present in DSI versus Matrigel, or conversely, factors that are present in
Matrigel but not DSI, and subsequently explore the removal/addition of those factors in
the DSI hydrogel organoid cultures.
One of the disadvantages of the DSI hydrogels versus Matrigel is the optical clarity, as
the DSI hydrogels were not fully transparent. This resulted in challenges with bright-field
imaging of specific cells within the organoids. The ECM-based hydrogels also
occasionally floated freely within the media, which was not ideal for imaging. Potential
approaches to address these barriers would be to make adjustments to the pepsin
digestion protocol, such as varying the ECM concentration or removing undigested
materials to reduce particulates. However, these changes may also impact the structure
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and composition of the ECM and ultimately its ability to promote organoid growth, so
further cell culture studies would be needed to confirm bioactivity if there are changes in
the ECM processing methods.
Matrigel-grown intestinal organoids are known to remain highly viable over many
passages. Thus, it would be interesting to explore whether the same viability is also
attainable for organoids grown in intestinal-ECM-derived organoids. The shear stress on
the DSI-grown organoids during passaging and the residual DSI remaining after
passaging could have affected their viability in the fresh DSI hydrogels. Treatment of the
DSI hydrogels with collagenase or cell recovery solution could aid in the release of cells
from the DSI hydrogels during passaging and reduce the potential damage to the
organoids caused by mechanical disruption which may be inhibiting organoid
growth56,127.
An additional focus of future studies should be directed towards enhancing the ability of
the alginate + DSI hydrogels to promote intestinal organoid growth and further
characterizing the capacity of the platform to support organoid survival. Other ways to
assess if organoids are viable are the LIVE/DEAD assay. Additionally, organoids could
be released from the alginate and resuspended in Matrigel to assess their viability.
Furthermore, alterations in the composition of the alginate + DSI may need to be
explored. Increasing the DSI concentration while decreasing the alginate concentration
may prove to be beneficial for providing the appropriate biochemical cues needed to
promote intestinal organoid growth, similar to the DSI alone gels. Similar to the DSI
alone gels, additional factors may be required which may already be present in
Matrigel, but not DSI. Therefore, exploring the addition of other growth factors or a
co-culture model with mesenchymal stromal cells, which can provide necessary growth
factors, may be required for the ISCs to expand and develop into intestinal organoids in
the composite alginate gels46,125.
The intestinal ECM has been demonstrated to provide biochemical cues capable of
supporting and promoting intestinal organoid growth. The need for tissue-specific ECM,
however, may require further investigation. The Clevers’ group provided evidence that
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porcine intestinal ECM hydrogels can promote the growth of organoids derived from
various endodermal tissues. Therefore, there is a need to explore if tissue-specific ECM is
required for intestinal organoid growth or if ECM derived from other tissues could
similarly support organoid growth. Finally, characterization of the organoids cultured
within ECM derived from other tissues may reveal whether important biological
differences in the properties of ECM derived from the intestine versus other tissues exist.
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Appendix A: Supplementary Data

Supplementary Figure A.1. Immunofluorescence staining of native and
decellularized small intestine with no primary antibody as a negative control for
IHC. Representative staining showing no detectable signal (red) for any of the ECM
markers in the no primary antibody control samples. No nuclei were also detected in the
DSI samples through DAPI staining (blue) for cell nuclei. (n=3 crosssections/decellularization batch, N=3 independent decellularization batches). Scale
bar=400 μm.
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